Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-01-15 08:06 |
Pharming announces the placement of €125 million senior unsecured convertible b…
|
English | 160.0 KB | ||
| 2020-01-14 08:32 |
Pharming announces the launch of an offering of approximately €125 million seni…
|
English | 146.8 KB | ||
| 2019-12-30 08:11 |
Pharming reacquires RUCONEST®-licensed territories from Sobi
|
English | 677.6 KB | ||
| 2019-10-24 08:31 |
Pharming Group reports strong interim financial results for the first nine mon…
|
English | 229.8 KB | ||
| 2019-10-24 08:30 |
Pharming released from CSL Behring court case
|
English | 133.9 KB | ||
| 2019-09-17 11:54 | English | 553.6 KB | |||
| 2019-08-13 08:07 |
Pharming acquires exclusive license to CDZ173, a late stage drug for the treatm…
|
English | 142.7 KB | ||
| 2019-07-25 08:54 |
Pharming Group reports strong financial results for the first half of 2019
|
English | 1.0 MB | ||
| 2019-06-11 08:28 |
Pharming announces initiation of clinical phase
|
English | 57.8 KB | ||
| 2019-05-23 08:49 |
Pharming Reports on Annual General Meeting of Shareholders
|
English | 132.3 KB | ||
| 2019-05-16 17:36 |
Pharming Today Celebrates "hae day :-)" - The Global Awareness Day for Heredita…
|
English | 162.3 KB | ||
| 2019-05-16 09:04 |
Pharming Group reports interim financial results
|
English | 193.6 KB | ||
| 2019-04-11 11:38 |
Pharming Group Announces Notice to Convene to Annual General Meeting of Shareho…
|
English | 379.0 KB | ||
| 2019-04-09 08:41 |
Pharming Group announces completion of minority investment in BioConnection BV
|
English | 134.1 KB | ||
| 2019-03-29 08:20 |
Pharming Group announces publication of its Annual Report 2018 and a provisiona…
|
English | 132.5 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
